About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Washington | 400 Studies

Clinical Trials Pancreatic CancerWashington

Pancreatic Cancer Clinical Trials in Washington

Find 400 clinical trials for pancreatic cancer near Washington. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 281-300 of 400 trials

CompletedGemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003546·Birmingham, Alabama and 47 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study of STRO-004 in Adults With Refractory/Recurrent Metastatic CancerThis is a study to evaluate the safety and preliminary anti-tumor activity of STRO-004 in adults with metastatic cancer.NCT07227168·San Diego, California and 8 others

RecruitingStudy of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerThe study is a randomized, double-blind, placebo-controlled, multicenter study of standard treatment with nab-paclitaxel and gemcitabine with or without SBP-101 in subjects…NCT05254171·Hot Springs, Arkansas and 92 others

TerminatedQUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing CancerThis is a phase 1b/2 study to evaluate the safety, tolerability, and efficacy of ETBX-011 vaccine used in combination with ALT-803 in subjects with locally advanced or metastatic…NCT03127098·Spokane, Washington

RecruitingTesting Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerThis phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have…NCT06958328·Gilbert, Arizona and 332 others

CompletedQUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the PancreasAMG 479 is an investigational fully human monoclonal antibody that targets type 1 insulin-like growth factor receptor (IGF-1R).NCT01231347·Fullerton, California and 151 others

CompletedStudy of Pegilodecakin (LY3500518) With FOLFOX Compared to FOLFOX Alone Second-line Tx in Participants With Metastatic Pancreatic CancerTo compare the efficacy of pegilodecakin in combination with FOLFOX versus FOLFOX alone in participants with metastatic pancreatic cancer as measured by overall survival.NCT02923921·Gilbert, Arizona and 129 others

UnknownCanady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor SitesThe study designed is to evaluate the safety of Canady Helios™ Cold Plasma Scalpel (CHCPS) in patients with solid tumors with carcinomatosis scheduled to undergo surgical…NCT04267575·Washington D.C., District of Columbia

RecruitingStudy of CP-383 in Patients With Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to learn if an investigational drug CP-383 works to treat advanced cancer. It will also learn about the safety of CP-383.NCT07030257·Denver, Colorado and 12 others

RecruitingTesting the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine TumorsThis phase I trial tests the safety, side effects, and best dose of sunitinib malate in combination with lutetium Lu 177 dotatate in treating patients with pancreatic…NCT05687123·Duarte, California and 9 others

RecruitingT Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon CancerThis phase I trial studies the side effects and best dose of autologous CD8+ and CD4+ transgenic T cells expressing high affinity KRASG12V mutation-specific T cell receptors…NCT06043713·Seattle, Washington

CompletedA Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic CancerStudy IPI-926-03 is a Phase 1b/2 clinical trial to evaluate IPI 926 in combination with gemcitabine in patients with previously untreated metastatic pancreatic cancer.NCT01130142·Tucson, Arizona and 27 others

RecruitingCollecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionThis study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection.NCT05334069·Anchorage, Alaska and 746 others

CompletedS1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryThis randomized phase II trial studies how well fluorouracil, irinotecan hydrochloride, and oxaliplatin (combination chemotherapy) works and compares to gemcitabine hydrochloride…NCT02562716·Birmingham, Alabama and 806 others

TerminatedGemcitabine and Pazopanib in Metastatic Pancreatic CancerTo determine the response rate and survival of gemcitabine and pazopanib in patients with metastatic pancreatic cancer.NCT01080248·St Louis, Missouri

TerminatedCT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic CancerThis pilot clinical trial studies how well computed tomography (CT) perfusion images work in assessing treatment response in patients with pancreatic cancer.NCT03012282·Seattle, Washington

CompletedA Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic CancerThis is a Phase 1/2 trial to evaluate the safety, tolerability, and efficacy of FG-3019 administered with gemcitabine and nab-paclitaxel in the treatment of locally advanced…NCT02210559·Scottsdale, Arizona and 7 others

UnknownPANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing RegimenThe objectives of this multi-center, randomized, controlled trial are to evaluate the safety and efficacy of PANVAC-VF in combination with Granulocyte-macrophage…NCT00088660·Mobile, Alabama and 61 others

CompletedA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.This is a study using sunitinib for patients ending treatment on a previous sunitinib malate protocol to continue to receive sunitinib.NCT00428220·Atlanta, Georgia and 112 others

Active not recruitingComparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET TrialThis phase II trial compares the effect of combination therapy with capecitabine and temozolomide to lutetium Lu 177 dotatate for the treatment of pancreatic neuroendocrine tumors…NCT05247905·Fairbanks, Alaska and 170 others

PreviousPage 15 of 20Next

Other Conditions in Washington

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia